Fullscript

FullscriptFullscript
Fullscript

Fullscript

A free supplement dispensing platform and patient adherence tool for healthcare practitioners.

DR 89Speed 592011Active765Ottawa, Canada
Rate

About

Fullscript empowers healthcare providers to deliver personalized care by offering tools for capturing clinical insights, creating smarter supplement plans, and promoting ongoing patient engagement. Their platform streamlines the entire whole-person care cycle, from diagnostics and high-quality supplement recommendations to ensuring patient adherence. Fullscript serves over 125,000 healthcare providers, including small practices and large networks, to enhance patient outcomes and practice efficiency.
Frequently asked

What does Fullscript do?

Fullscript empowers healthcare providers to deliver personalized care by offering tools for capturing clinical insights, creating smarter supplement plans, and promoting ongoing patient engagement. Their platform streamlines the entire whole-person care cycle, from diagnostics and high-quality supplement recommendations to ensuring patient adherence. Fullscript serves over 125,000 healthcare providers, including small practices and large networks, to enhance patient outcomes and practice efficie…

What is Fullscript's revenue?

StartupHub estimates Fullscript's annual revenue at $119.7M (range $62.8M to $150.8M, 65% confidence), based on comparable companies in the sector.

What is Fullscript's valuation?

StartupHub estimates Fullscript's effective valuation at $2.6B (range $1.8B to $3.4B, 42% confidence), based on comparable companies in the sector.

Where is Fullscript headquartered?

Fullscript is headquartered in Ottawa, Canada.

When was Fullscript founded?

Fullscript was founded in 2011.

What industry does Fullscript operate in?

Fullscript operates in HealthTech, E-commerce, Pharmacy, Supplement Dispensing, Patient Adherence, Integrative Medicine.

How many employees does Fullscript have?

Fullscript has approximately 765 people on record.

HEADCOUNT
765
DOMAIN RATING
89
Comments

No comments yet. Be the first to share your take.